Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2013 | 0 | 7.374.574 | 1.003.542 | 2 |
Total number of partners: 8
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 8
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2013-12-01 | "The development of a novel therapeutic vaccine for the selective treatment of the autoimmune disorder, Graves’ disease." | DAVIAD | participant | 5.924.893 | 4 |
2013-02-01 | LSE TECHNOLOGY APPROACH TO GENERATE INNOVATIVE KINASE INHIBITOR DRUGS | LSE | participant | 1.449.681 | 6 |